ArticleFrontiers in oncology2024
Outcomes and patterns of use of Radium-223 in metastatic castration-resistant prostate cancer.
Urbano Anido-Herranz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it